We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$8.87B
AUM Growth
+$1.06B
Cap. Flow
+$639M
Cap. Flow %
7.2%
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,198
Closed
351

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$37.2M
2
LIN icon
Linde
LIN
+$31.4M
3
TTWO icon
Take-Two Interactive
TTWO
+$30M
4
FISV
Fiserv Inc
FISV
+$27.4M
5
WMT icon
Walmart Inc
WMT
+$25.5M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$46.1M
2
PYPL icon
PayPal
PYPL
+$31.4M
3
AAPL icon
Apple
AAPL
+$31.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$28M
5
MRK icon
Merck
MRK
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 18.34%
2 Consumer Discretionary 15.85%
3 Healthcare 13.89%
4 Industrials 12.4%
5 Financials 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRYS icon
3001
Krystal Biotech
KRYS
$9.66B
-48
Closed -$4K
LAKE icon
3002
Lakeland Industries
LAKE
$119M
-17,284
Closed -$482K
LBRDA icon
3003
Liberty Broadband Class A
LBRDA
$5.16B
-5,511
Closed -$800K
LIND icon
3004
Lindblad Expeditions
LIND
$2.22B
-11,661
Closed -$220K
LKFN icon
3005
Lakeland Financial Corp
LKFN
$1.53B
-29,155
Closed -$2.02M
LMND icon
3006
Lemonade
LMND
$4.1B
-28,150
Closed -$2.62M
LMNR icon
3007
Limoneira
LMNR
$251M
-10,299
Closed -$180K
LPCN icon
3008
Lipocine
LPCN
$17.6M
-3,247
Closed -$83K
LPL icon
3009
LG Display
LPL
$3.3B
-53,566
Closed -$535K
LQDA icon
3010
Liquidia Corp
LQDA
$8.02B
-10,240
Closed -$28K
LRN icon
3011
Stride
LRN
$3.43B
-12,196
Closed -$367K
LSAK icon
3012
Lesaka Technologies
LSAK
$420M
-27,223
Closed -$152K
LXRX icon
3013
Lexicon Pharmaceuticals
LXRX
$1.1B
-12,943
Closed -$76K
MAG
3014
DELISTED
MAG Silver
MAG
-96,079
Closed -$1.44M
MANU icon
3015
Manchester United
MANU
$3.73B
-27,915
Closed -$439K
MASS icon
3016
908 Devices
MASS
$364M
-7,664
Closed -$372K
MBRX icon
3017
Moleculin Biotech
MBRX
$2.91M
-71
Closed -$109K
MCS icon
3018
Marcus Corp
MCS
$945M
-10,727
Closed -$214K
MG icon
3019
Mistras Group
MG
$512M
-15,002
Closed -$171K
MITK icon
3020
Mitek Systems
MITK
$834M
-20,488
Closed -$299K
MLSS icon
3021
Milestone Scientific
MLSS
$42.6M
-31,363
Closed -$112K
MMI icon
3022
Marcus & Millichap
MMI
$1.19B
-36,709
Closed -$1.24M
MMYT icon
3023
MakeMyTrip
MMYT
$5.64B
-10,064
Closed -$318K
ORIO
3024
Orion Digital Corp
ORIO
$15.3M
-7,317
Closed -$187K
MP icon
3025
MP Materials
MP
$9.1B
-13,100
Closed -$471K

Similar funds

Cubist Systematic Strategies's Q2 2021 Portfolio in Review

As of Q2 2021, Cubist Systematic Strategies held 3,246 positions worth $8.87B, up 14% from $7.81B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Cubist Systematic Strategies deployed $639M of net new capital in Q2 2021, opening 442 new positions and adding to 1,245 existing holdings. Its largest new stake was American Tower: 39,022 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Aptiv, an estimated $46.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2021 buy was American Tower: 39,022 shares worth $10.5M.
  • Cubist Systematic Strategies added most to Okta in Q2 2021, an estimated $37.2M increase.
  • Cubist Systematic Strategies's biggest Q2 2021 reduction was Aptiv, cutting an estimated $46.1M.
  • Cubist Systematic Strategies fully exited Toro Company in Q2 2021, selling an estimated $7.31M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.2% of its $8.87B portfolio in Q2 2021.
  • Cubist Systematic Strategies opened 442 new positions and closed 351 in Q2 2021.
  • Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $8.87B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.